ORGO - Organogenesis Holdings Inc logo

Organogenesis Holdings Inc

ORGO

Organogenesis Holdings Inc. develops and commercializes regenerative medicine products for advanced wound care and surgical markets, including amnion grafts, bioengineered skin substitutes, and antimicrobial barriers, serving hospitals and clinics in the U.S.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago โ†’$94today

Score Overview

1 Year
Score
Net Growth-343.66%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-18.91%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.4
Net Growth-195.78%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth-2.31%
Rev Trend40%
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-41x
Net Trend44%
Net Income Consistency
Rev Growthโ€”
Rev Trend67%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Organogenesis Holdings Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. ORGO does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 0.99โ€”
1 Year2025-10-23
$ 4.11-75.83%
5 Years2021-10-22
$ 10.60-90.63%
All Time2017-01-05
$ 9.75-89.81%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 456M-$ 90M$ 46M
2025$ 563M$ 37M$ 93M
2024$ 482M$ 861K$ 135M
2023$ 433M$ 4M$ 104M
2022$ 450M$ 15M$ 102M
2021$ 467M$ 94M$ 113M
2020$ 338M$ 17M$ 84M
2019$ 260M-$ 38M$ 60M
2018$ 193M-$ 64M$ 21M
IPO2017$ 0.00-$ 2M$ 125.89K
ORGO - Organogenesis Holdings Inc logo

Organogenesis Holdings Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 338M to $ 563M and net income grew from $ 17M to $ 37M. Revenue increased in 2 of those 5 years; net income in 1.

Organogenesis Holdings Inc currently holds a 5-year HDB Score of 2.4 out of 10. How the HDB Score is calculated.

Membership

Explore ORGO with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies